Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ruxolitinib”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06660355
What this trial is testing

Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy

Who this might be right for
Chronic Graft-versus-host Disease (cGVHD)
H. Lee Moffitt Cancer Center and Research Institute 120
Testing effectiveness (Phase 2)Study completedNCT03774082
What this trial is testing

Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant

Who this might be right for
Graft vs Host Disease
Novartis Pharmaceuticals 46
Testing effectiveness (Phase 2)Study completedNCT05750823
What this trial is testing

Assess the Safety and Efficacy of Ruxolitinib Cream in Participants With Genital Vitiligo

Who this might be right for
Nonsegmental Vitiligo With Genital Involvement
Incyte Corporation 49
Early research (Phase 1)Active Not RecruitingNCT05936359
What this trial is testing

Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

Who this might be right for
Myeloproliferative Neoplasms
Incyte Corporation 160
Testing effectiveness (Phase 2)Study completedNCT04908280
What this trial is testing

Study of Ruxolitinib Cream for the Treatment of Discoid Lupus Erythematosus

Who this might be right for
Discoid Lupus Erythematosus
University of Rochester 10
Testing effectiveness (Phase 2)Study completedNCT04338958
What this trial is testing

Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation

Who this might be right for
Covid-19
University of Jena 193
Early research (Phase 1)Study completedNCT06310304
What this trial is testing

Evaluate the Relative Bioavailability of Ruxolitinib Extended Release (XR) Tablets Compared With Ruxolitinib Immediate Release (IR) Tablets Administered Orally in Healthy Participants.

Who this might be right for
Healthy Participants
Incyte Corporation 24
Large-scale testing (Phase 3)Study completedNCT01632904
What this trial is testing

Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study

Who this might be right for
Polycythemia Vera
Incyte Corporation 110
Testing effectiveness (Phase 2)Ended earlyNCT00638378
What this trial is testing

Study of Ruxolitinib (INCB018424) Administered Orally to Patients With Androgen Independent Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Incyte Corporation 22
Testing effectiveness (Phase 2)Study completedNCT00550043
What this trial is testing

A Study Exploring the Safety, Tolerability and Efficacy of a 4 Week Course of INCB018424 in Subjects With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Incyte Corporation 50
Early research (Phase 1)Active Not RecruitingNCT07340138
What this trial is testing

Study of Pelabresib add-on to Ruxolitinib in Japanese Adult Patients With Myelofibrosis

Who this might be right for
Primary Myelofibrosis (PMF)Post-polycythemia Vera Myelofibrosis (Post-PV MF)Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
Novartis Pharmaceuticals 3
Testing effectiveness (Phase 2)Study completedNCT02928978
What this trial is testing

Ruxolitinib for Premalignant Breast Disease

Who this might be right for
Ductal Carcinoma In SituAtypical Lobular HyperplasiaAtypical Ductal Hyperplasia+1 more
Julie Nangia 84
Testing effectiveness (Phase 2)UnknownNCT03795909
What this trial is testing

Ruxolitinib Combined With Dexamethasone for HLH

Who this might be right for
Hemophagocytic Lymphohistiocytosis
Capital Research Institute of Pediatrics 50
Testing effectiveness (Phase 2)Looking for participantsNCT06128070
What this trial is testing

Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome
City of Hope Medical Center 40
Testing effectiveness (Phase 2)Ended earlyNCT03395340
What this trial is testing

Topical Ruxolitinib for Cutaneous Chronic Graft Versus Host Disease (cGVHD)

Who this might be right for
Graft Versus Host DiseaseJNS KinaseTopical Administration
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 1
Large-scale testing (Phase 3)Study completedNCT04921969
What this trial is testing

Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)

Who this might be right for
Atopic Dermatitis
Incyte Corporation 330
Large-scale testing (Phase 3)Study completedNCT05764161
What this trial is testing

Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)

Who this might be right for
Prurigo Nodularis
Incyte Corporation 190
Early research (Phase 1)Looking for participantsNCT06034002
What this trial is testing

Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

Who this might be right for
Myeloproliferative Neoplasms
Incyte Corporation 290
Testing effectiveness (Phase 2)Study completedNCT01965119
What this trial is testing

Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-cell Lymphoma

Who this might be right for
Relapsed or Refractory Hodgkin LymphomaPrimary Mediastinal Large B-cell Lymphoma
Samsung Medical Center 20
Large-scale testing (Phase 3)Looking for participantsNCT06804811
What this trial is testing

Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo

Who this might be right for
NonSegmental Vitiligo
Incyte Corporation 250
Next Page